IL-37 (Protein|Antibody|cDNA Clone|ELISA Kit)

All IL-37 reagents are produced in house and quality controlled, including 3 IL-37 Antibody, 1 IL-37 ELISA, 1 IL-37 Gene, 1 IL-37 Protein, 1 IL-37 qPCR. All IL-37 reagents are ready to use.

Recombinant IL-37 proteins are expressed by E. coli with fusion tags as Native.

IL-37 antibodies are validated with different applications, which are ELISA, ELISA(Cap).

IL-37 cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each IL-37 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

IL-37 ELISA Kit are quality controlled by 8 internation QC standard which guarantee every ELISA Kit with high quality.

IL-37 Protein (1)


IL-37 Protein, Human, Recombinant


Expression host: E. coli

Human IL37 / IL1F7 / IL-1H4 Protein 8458

IL-37 Antibody (3)

Application Clonality

Anti-IL-37 Antibody


Specificity: Human

Application: ELISA,ELISA(Cap)

Clonality: MAb

Anti-IL-37 Antibody


Specificity: Human

Application: ELISA

Clonality: PAb

Anti-IL-37 Antibody


Specificity: Human

Application: ELISA

Clonality: PAb


IL-37 ELISA KIT & match antibody elias pair set ( 1 )

IL-37 Matched ELISA Antibody Pair Set,Human


Assay Range: 46.875 pg/ml

Human IL-37 ELISA Pair Set Standard Curve 19585

IL-37 cDNA Clone (1)


IL-37 qPCR Primer (1)

Interleukin 1 family member 7, or interleukin 37 (IL1F7 / IL37 / IL-1H4) is a secretory protein belonging to the Interleukin 1 family. IL-1F7 was localized in human peripheral monocytic cells. It has been localized the expression of IL-1F7b protein in discrete cell populations including plasma cells and tumor cells. These data suggest that IL-1F7 may be involved in immune response, inflammatory diseases and / or cancer. Through constructing an adenoviral vector that allows high level expression in murine and human cells, it has been demonstrated that the ability of adenovirus-mediated gene transfer of IL1F7 to induce an IL-12- and Fas ligand-dependent anti-tumor response. Complete inhibition of tumor growth was observed following multiple injections of IL1F7 in the most animals. These results suggest that IL1F7 could play a role in both innate and adaptive immune responses, similar to IL-18. Moreover, IL1F7 could be useful for cancer gene therapy.